BAIN CAPITAL LIFE SCIENCES
Bain Capital Life Sciences Fund specializes in buyouts, inflection capital, growth capital, turnaround, and private equity investments.
BAIN CAPITAL LIFE SCIENCES
Industry:
Business Development Finance Financial Services
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.baincapitallifesciences.com
Total Employee:
11+
Status:
Active
Contact:
617-516-2000
Similar Organizations
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Icon Bioscience
Icon Bioscience develops and commercializes novel ophthalmic pharmaceuticals through a proprietary drug delivery platform.
Polaris Partners
Polaris Partners invests in healthcare and technology companies ​across all stages from founding to profitable growth.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-31 | JenaValve Technology | Bain Capital Life Sciences investment in Series C - JenaValve Technology | 100 M USD |
| 2022-07-12 | Areteia Therapeutics | Bain Capital Life Sciences investment in Series A - Areteia Therapeutics | 350 M USD |
| 2022-07-08 | Annexon Biosciences | Bain Capital Life Sciences investment in Post-IPO Equity - Annexon Biosciences | 130 M USD |
| 2022-06-30 | X4 Pharmaceuticals | Bain Capital Life Sciences investment in Post-IPO Equity - X4 Pharmaceuticals | 55 M USD |
| 2022-03-16 | 2seventy bio | Bain Capital Life Sciences investment in Post-IPO Equity - 2seventy bio | 170 M USD |
| 2021-12-17 | EQRx | Bain Capital Life Sciences investment in Post-IPO Equity - EQRx | 1.2 B USD |
| 2021-12-07 | Freenome | Bain Capital Life Sciences investment in Series D - Freenome | 300 M USD |
| 2021-08-11 | Tango Therapeutics | Bain Capital Life Sciences investment in Post-IPO Equity - Tango Therapeutics | 186 M USD |
| 2021-07-20 | Amylyx Pharmaceuticals | Bain Capital Life Sciences investment in Series C - Amylyx Pharmaceuticals | 135 M USD |
| 2021-07-15 | Imperative Care | Bain Capital Life Sciences investment in Series D - Imperative Care | 260 M USD |
Official Site Inspections
http://www.baincapitallifesciences.com Semrush global rank: 2.43 M Semrush visits lastest month: 7.43 K
- Host name: 104.18.28.132
- IP address: 104.18.28.132
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 